Olink investor relations material
Listen to the latest call from Olink
Olink Holding AB, founded in Sweden but US listed, provides proteomics and genomics solutions to understand biomarkers for various diseases. It offers Olink Discovery, a solution that allows users to target and validate thousands of proteins in one simple workflow; and Olink Proteomics, a platform which is aimed at understanding how proteins affect gene expression, cell signaling, and protein-protein interactions. Olink went public March 2021 and is headquartered in Uppsala, Sweden.